Cure8
Robotic surgery in inflammatory bowel disease: a systematic review
International Journal of Colorectal Disease

Cure8 research brief

Robotic surgery in inflammatory bowel disease: a systematic review

2 min read
Procedures and surgery Systematic Review or Meta Analysis Clinicians Adult patients Post Surgery Patients Patients On Biologics Inflammatory bowel disease

Why This Matters

This review summarizes evidence on robotic surgery for IBD, which could affect surgical choices and expectations about recovery and risks for patients needing colorectal or pelvic operations. It suggests robotic approaches are feasible and may reduce conversion to open surgery in complex cases.

Who Should Pay Attention

Patients with Crohn’s disease or ulcerative colitis who may need surgery; colorectal surgeons and surgical teams; clinicians advising surgical decisions.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthMetadata only

What To Know

This systematic review pooled 34 studies comparing robotic versus conventional minimally invasive or open surgery for inflammatory bowel disease (Crohn’s disease and ulcerative colitis).

The review reports that robotic procedures tend to have longer operative times but similar rates of postoperative morbidity, major complications, anastomotic leak, reoperation, and mortality compared with other approaches. Robotic approaches showed lower conversion-to-open rates, potentially helpful in complex inflammatory or pelvic procedures.

Length of stay and blood loss were generally similar or sometimes lower with robotic cohorts. The article is a literature synthesis (systematic review) rather than a randomized trial; the authors conclude robotic surgery is feasible and safe but call for higher-quality prospective studies to define its role.

This is about perioperative outcomes and technical feasibility, not about long-term disease control or medication management.

Keep In Mind

The review is based on 34 mostly non-randomized studies with heterogeneous methods. Reported advantages (lower conversion rates) are most relevant to complex inflammatory or pelvic surgeries; definitive superiority requires higher-quality prospective trials.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationInternational Journal of Colorectal Disease
PublisherSpringer Science and Business Media LLC
AuthorsAlexandra Damasio Todescatto, Carlos Ramon Silveira Mendes, Sergio Eduardo Alonso Araujo +1 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedAug 4, 2026, 12:00 AM
Content availableMetadata only

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →